Vir Biotechnology, Inc. VIR Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$442.72M+23.4% | -$437.99M+16.1% | -$499.65M+6.3% | -$550.23M-13.9% | -$577.65M-7.1% | ||
| $11.62M-10.0% | $11.68M-19.8% | $11.67M-27.8% | $11.57M-34.9% | $12.91M-28.7% | ||
| $47.1M-31.5% | $49.07M-37.5% | $53.71M-40.9% | $59.05M-41.6% | $68.76M-37.3% | ||
| —— | —— | —— | $8.61M+222% | -$3.14M— | ||
| —— | —— | -$68.1M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$7.85M+62.2% | -$7.37M+68.0% | -$17.64M-30.0% | -$18.73M-30.4% | -$20.76M-48.2% | ||
| -$446.05M-7.5% | -$391.78M+12.2% | -$453.54M+2.8% | -$457.45M-1.4% | -$415.08M+45.6% | ||
| $3.59M-49.1% | $4.83M-33.8% | $6.48M-5.3% | $8.93M+14.7% | $7.06M-57.4% | ||
| $871.01M+2.9% | $886.33M-28.3% | $791.37M-58.2% | $767.07M-64.4% | $846.09M-61.4% | ||
| $1.07B-26.1% | $1.2B-30.9% | $1.16B-46.2% | $1.22B-45.7% | $1.45B-37.2% | ||
| $195.39M-67.3% | $310.37M-37.8% | $364.46M— | $442.61M— | $597.77M— | ||
| $163.7M+28,669% | $1.35M+70.8% | $1.44M+81.9% | $1.41M+32.5% | $569K-59.2% | ||
| $165.71M+3,328% | $3.79M-13.7% | $4.01M-16.6% | $3.94M-22.0% | $4.83M-8.6% | ||
| —— | —— | -$85.07M— | —— | —— | ||
| -$5.78M+37.5% | -$9.47M-75.5% | -$10.09M— | -$9.13M— | -$9.25M— | ||
| —— | —— | —— | —— | —— | ||
| $9.65M-28.7% | $11.57M-18.2% | $18.51M+109% | $20.52M+262% | $13.53M+245% | ||
| —— | —— | -$68.1M— | —— | —— | ||
| -$7.85M+62.2% | -$7.37M+68.0% | -$17.64M-30.0% | -$18.73M-30.4% | -$20.76M-48.2% | ||
| $18.19M— | $12.64M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $5.2M+5.6% | $4.98M-5.1% | $4.75M-14.9% | $4.69M-24.1% | $4.92M-29.0% | ||
| $1.07B-26.1% | $1.2B-30.9% | $1.16B-46.2% | $1.22B-45.7% | $1.45B-37.2% | ||
| —— | —— | $2.82M+207% | $2.79M+205% | $3.12M+485% | ||
| —— | —— | —— | —— | —— | ||
| -$7.85M+62.2% | -$7.37M+68.0% | -$17.64M-30.0% | -$18.73M-30.4% | -$20.76M-48.2% | ||
| -$449.64M-6.5% | -$396.61M+12.6% | -$460.02M+2.8% | -$466.38M-1.7% | -$422.14M+45.8% | ||
| -$449.64M-6.5% | -$396.61M+12.6% | -$460.02M+2.8% | -$466.38M-1.7% | -$422.14M+45.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Vir Biotechnology, Inc. generate?
- Vir Biotechnology, Inc. (VIR) generated -$446.1M in operating cash flow over the trailing twelve months.
- What is Vir Biotechnology, Inc.'s free cash flow?
- After $3.6M of capital expenditures, Vir Biotechnology, Inc.'s free cash flow was -$449.6M over the trailing twelve months, down 6.5% year over year.
- Where does Vir Biotechnology, Inc.'s cash flow data come from?
- Every line is extracted from Vir Biotechnology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
